NCT04761393 - Characterizing Matrix Metalloproteinase-12 (MMP12) in Sputum | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 29, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions

Emphysema

Interventions

PROCEDURE

Hyperpolarized 129Xe (Xenon) diffusion-weighted MRI

Participants will inhale a one litre gas mixture containing hyperpolarized 129Xe mixed with nitrogen (N2) or helium (4He) from a one litre dose bag. Breath-hold will be up to 16 seconds

Trial Locations (1)

L8N 4A6

RECRUITING

Firestone Institute for Respiratory Health, St. Joseph's Healthcare, Hamilton